机译:vorasidenib(AG-881):突变体IDH1和2的一类级,脑渗透双抑制剂,用于治疗胶质瘤
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Viva Biotech Shanghai 201203 Peoples R China;
Wuxi Biortus Biosci Co Ltd Jiangyin 214437 Peoples R China;
PharmaResources Shanghai 201201 Peoples R China;
PharmaResources Shanghai 201201 Peoples R China;
PharmaResources Shanghai 201201 Peoples R China;
ChemPartner Shanghai 201203 Peoples R China;
ChemPartner Shanghai 201203 Peoples R China;
ChemPartner Shanghai 201203 Peoples R China;
ChemPartner Shanghai 201203 Peoples R China;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Mem Sloan Kettering Canc Ctr New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr New York NY 10065 USA;
Agios Pharmaceut Inc Cambridge MA 02139 USA;
Isocitrate dehydrogenase; mutant IDH1/mIDH2; AG-881; vorasidenib; 2-hydroxyglutarate;
机译:vorasidenib(AG-881):突变体IDH1和2的一类级,脑渗透双抑制剂,用于治疗胶质瘤
机译:IDH1突变阳性血液系统恶性肿瘤接受AG-120(突变IDH1的第一个抑制剂)的患者通过下一代测序确定IDH1突变的负担和清除率
机译:IDH1突变阳性血液系统恶性肿瘤接受AG-120(突变IDH1的第一个抑制剂)的患者通过下一代测序确定IDH1突变的负担和清除率
机译:胶质瘤细胞系中突变体和野生型IDH1相互作用网络的鉴定
机译:Vorasidenib(AG-881):突变IDH1和2用于治疗神经胶质瘤
机译:ACTR-46。 AG120,一种复发性或渐进式IDH1突变胶质瘤患者的一类突变体IDH1抑制剂:1型胶质瘤扩张队列的结果